# FDA Inspection 1236866 - AustarPharma, LLC - December 04, 2024

Source: https://www.keypedia.com/records/fda_inspections/austarpharma-llc/c0b3d431-5609-47c0-897e-9f1b9d5346b2
Source feed: FDA_Inspections

> FDA Inspection 1236866 for AustarPharma, LLC on December 04, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1236866
- Company Name: AustarPharma, LLC
- Inspection Date: 2024-12-04
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1236866 - 2024-12-04](https://www.keypedia.com/records/fda_inspections/austarpharma-llc/10e2a2db-5b56-49da-a13d-88339fba8141)
- [FDA Inspection 1201798 - 2023-04-05](https://www.keypedia.com/records/fda_inspections/austarpharma-llc/6635b5b3-6703-455e-b2f0-5a25ec8bc2b8)
- [FDA Inspection 1037881 - 2018-01-05](https://www.keypedia.com/records/fda_inspections/austarpharma-llc/f067f0ec-7152-46ca-bde6-1691f99a71ce)
- [FDA Inspection 973353 - 2016-05-25](https://www.keypedia.com/records/fda_inspections/austarpharma-llc/3f12910e-b9e3-4656-91ff-98cd46d9cf4a)
- [FDA Inspection 858222 - 2013-12-18](https://www.keypedia.com/records/fda_inspections/austarpharma-llc/6c812746-8af1-4b01-90ba-3faa8c3c3f2e)

Company: https://www.keypedia.com/companies/austarpharma-llc/05a402ea-dcb1-4900-9553-0a3a1b908183

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c